DE eng

Search in the Catalogues and Directories

Hits 1 – 9 of 9

1
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
BASE
Show details
2
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
Abstract: IntroductionFrontotemporal lobar degeneration (FTLD) is the most common form of dementia for those under 60years of age. Increasing numbers of therapeutics targeting FTLD syndromes are being developed.MethodsIn March 2018, the Association for Frontotemporal Degeneration convened the Frontotemporal Degeneration Study Group meeting in Washington, DC, to discuss advances in the clinical science of FTLD.ResultsChallenges exist for conducting clinical trials in FTLD. Two of the greatest challenges are (1) the heterogeneity of FTLD syndromes leading to difficulties in efficiently measuring treatment effects and (2) the rarity of FTLD disorders leading to recruitment challenges.DiscussionNew personalized endpoints that are clinically meaningful to individuals and their families should be developed. Personalized approaches to analyzing MRI data, development of new fluid biomarkers and wearable technologies will help to improve the power to detect treatment effects in FTLD clinical trials and enable new, clinical trial designs, possibly leveraged from the experience of oncology trials. A computational visualization and analysis platform that can support novel analyses of combined clinical, genetic, imaging, biomarker data with other novel modalities will be critical to the success of these endeavors.
Keyword: Acquired Cognitive Impairment; Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD); Alzheimer's Disease Related Dementias (ADRD); ARTFL; Atrophy; Biomarker; Biomarkers; Brain Disorders; C9orf72; Clinical Research; Clinical Sciences; Clinical trial; Clinical Trials and Supportive Activities; Clinical Trials as Topic; Congresses as Topic; Dementia; Frontotemporal dementia; Frontotemporal Dementia (FTD); Frontotemporal Lobar Degeneration; FTD; FTLD; Genetics; Geriatrics; GRN; Humans; LEFFTDS; Magnetic Resonance Imaging; MAPT; Neurodegenerative; Neurosciences; Primary progressive aphasia; Progressive supranuclear palsy; Rare Diseases
URL: https://escholarship.org/uc/item/13t6f67b
BASE
Hide details
3
An Open-Labeled Trial of Bromocriptine in Nonfluent Aphasia: A Qualitative Analysis of Word Storage and Retrieval
In: Brain & language. - Orlando, Fla. [u.a.] : Elsevier 74 (2000) 2, 141-156
OLC Linguistik
Show details
4
An open-label trial of bromocriptine in nonfluent aphasia : a qualitative analysis of word storage and retrieval
In: Brain & language. - Orlando, Fla. [u.a.] : Elsevier 74 (2000) 2, 141-156
BLLDB
Show details
5
INTRODUCTION - Apraxia in Corticobasal Degeneration
In: Brain and cognition. - San Diego, Calif. [u.a.] : Elsevier Science 40 (1999) 2, 336-354
OLC Linguistik
Show details
6
Adynamic Aphasia: A Transcortical Motor Aphasia with Defective Semantic Strategy Formation
In: Brain & language. - Orlando, Fla. [u.a.] : Elsevier 57 (1997) 3, 374-393
OLC Linguistik
Show details
7
Adynamic aphasia : a transcortical motor aphasia with defective semantic strategy formation
In: Brain & language. - Orlando, Fla. [u.a.] : Elsevier 57 (1997) 3, 374-393
BLLDB
Show details
8
Adynamic Aphasia: A Transcortical Motor Aphasia with Defective Semantic Strategy Formation
Department of Neurology, College of Medicine, University of Florida ( host institution ); Gold, Michael ( author ); Nadeau, Stephen E. ( author ). - : Elsevier Inc., 1997
BASE
Show details
9
Adynamic Aphasia: A Transcortical Motor Aphasia with Defective Semantic Strategy Formation
BASE
Show details

Catalogues
0
0
3
0
0
0
0
Bibliographies
2
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
4
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern